Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
OA06 - Early Stage Lung Cancer: Outcomes and Interventions
- 13:30 - 15:00
- 9/24/2018
- Location: Room 202 BD
- Type: Oral Abstract Session
- Track: Treatment of Early Stage/Localized Disease
-
+
OA06.01 - Case-Series Study in Ever- and Never-Smoking Females and Males with NSCLC: Exposures, Tumor Factors, Biology and Survival (SWOG S0424)
13:30 - 13:40 | Presenter: Kathy S. Albain | Author(s): Amy K. Darke, Philip Christopher Mack, Mary W. Redman, Ting-Yuan D. Cheng, James Moon, William S. Holland, Alain C. Borczuk, Christopher H. Chay, Paul T. Morris, Eric Vallieres, Robert A. Kratzke, Julian R. Molina, Jill M. Kolesar, Yuhchyau Chen, Robert M. Macrae, Seiji Matsumoto, Mary Reid, Gary R. Zirpoli, Warren Davis, Rochelle P. Ondracek, Wiam Bshara, Angela R. Omilian, David R. Gandara, Karen Kelly, Regina M. Santella, Christine B. Ambrosone
- Abstract
Loading...
-
+
P1.04 - Immunooncology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.04-09 - Immunomodulatory Effects of Afatinib and Pembrolizumab in EGFR-Mutant NSCLC with Progression on Prior EGFR-TKI
16:45 - 18:00 | Presenter: Jonathan W Riess | Author(s): Karen Kelly, Kurt Alex Schalper, Michiko Shimoda, Steffany Lim, Arta M Monjazeb, Kathleen Danenberg, Elizabeth H Moore, Laurel Beckett, Philip Christopher Mack, Emanual M Maverakis, David R. Gandara
- Abstract
Loading...
-
+
P1.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.16-47 - Adjuvant Targeted Therapy Following Standard Adjuvant Therapy for Resected NSCLC: An Initial Report from ALCHEMIST (Alliance A151216)
16:45 - 18:00 | Presenter: Geoffrey R. Oxnard | Author(s): Sumithra Mandrekar, Shauna Hillman, Angelina Tan, Ramaswamy Govindan, Dennis Wigle, Shakun Malik, Colleen Watt, David E Gerber, Jamie E Chaft, Suzanne Dahlberg, Karen Kelly, Meredith Faggen, Philip Stella, Karim Tazi, David R. Gandara, Suresh S. Ramalingam, Thomas E. Stinchcombe
- Abstract
Loading...
-
+
OA10 - Right Patient, Right Target & Right Drug - Novel Treatments and Research Partnerships
- 10:30 - 12:00
- 9/25/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA10.04 - Afatinib With or Without Cetuximab for EGFR-Mutant Non-Small Cell Lung Cancer: Safety and Efficacy Results from SWOG S1403
11:05 - 11:15 | Presenter: Sarah B Goldberg | Author(s): Mary W. Redman, Rogerio Lilenbaum, Katerina Politi, Thomas E. Stinchcombe, Leora Horn, Everett H. Chen, Sandeep Mashru, Scott N. Gettinger, Mary Ann Melnick, Jieling Miao, James Moon, Karen Kelly, David R. Gandara
- Abstract
Loading...
-
+
MS18 - Management of SCLC Patients Not Represented in Clinical Trials
- 13:30 - 15:00
- 9/25/2018
- Location: Room 206 BD
- Type: Mini Symposium
- Track: Small Cell Lung Cancer/NET
-
+
MS18.02 - Treatment of Elderly Patients with SCLC
13:50 - 14:10 | Presenter: Karen Kelly
- Abstract
No abstract available for this presentation
-
+
P3.13 - Targeted Therapy (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.13-26 - Outcomes of Patients with Metastatic Lung Cancer Presented in a Multidisciplinary Molecular Tumor Board
12:00 - 13:30 | Presenter: Lisa Pei Chu | Author(s): Karen Kelly, David R. Gandara, Primo Lara, Alexander Borowsky, Frederick Meyers, John McPherson, Rachel L Erlich, Nava Almog, Alexa B Schrock, Siraj M Ali, Jeffrey S. Ross, Vincent A Miller, Andreas Heilmann, Jonathan W Riess
- Abstract
Loading...